New directions in the therapeutic strategy to improve survival outcomes in patients with non-Hodgkin's lymphoma. Summary

Oncologist. 2009:14 Suppl 2:52-4. doi: 10.1634/theoncologist.2009-S2-52.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Humans
  • Lymphoma, Non-Hodgkin / radiotherapy*
  • Radioimmunotherapy / methods*
  • Treatment Outcome
  • Yttrium Radioisotopes / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Yttrium Radioisotopes
  • ibritumomab tiuxetan